BioHealth News Archive
GSK to streamline research in efficiency drive
GlaxoSmithKline will cut more than 30 drug development programmes and may sell its rare diseases unit, as the FTSE 100 group seeks to inject…
Read More
Mobile Health for Tuberculosis Treatment
The day after emocha® Mobile Health, Inc., launched in 2013, CEO Sebastian Seiguer (pronounced SAY-ger) heard about a 3-year-old tuberculosis (TB) patient being treated…
Read More
The Startling History Behind Merck’s New Cancer Blockbuster
No area is hotter or attracting more dollars in pharma than immuno-oncology–the idea of harnessing the immune system to fight cancer. My fellow Forbes…
Read More
Emergent BioSolutions Secures Exclusive Worldwide Rights to Valneva’s Zika Vaccine Technology – NASDAQ.com
Emergent BioSolutions Inc. (NYSE:EBS) today announced a licensing agreement with Valneva SE for global exclusive rights to Valneva's Zika vaccine technology, ZIKV. Emergent and…
Read More
IonQ Raises $20M Series B Round Led By NEA, GV To Advance Quantum Computing For Commercial
IonQ, an early-stage company developing quantum computing for commercial applications, today announced completion of a $20 million series B round led by New Enterprise…
Read More
A Better Way to Design Clinical Trials | INSEAD Knowledge
A new type of trial design can help the healthcare industry bring beneficial therapies to patients sooner and stop researching inferior ones earlier. Value…
Read More
5th Pediatric Device Symposium – Organized by Sheikh Zayed Institute for Pediatric Surgical Innovation
Calling All Medical Device Innovators! We are now accepting proposals for our annual $250K pediatric medical device pitch competition. Up to six innovations will…
Read More
TO Health!
About the Cluster Action Plan TOHealth! brought together diverse participants from Human Health and Sciences ecosystem in the Toronto region to develop Ontario’s first…
Read More
And the 2017 Prix Galien USA Nominees are …
The Galien Foundation announced today the 2017 Annual Prix Galien USA Awards Nominees. Worldwide regarded as the equivalent of the Nobel Prize in biopharmaceutical…
Read More
Canaan unveils $800M fund for fresh wave of biotech bets – FierceBiotech
Canaan has put together an $800 million investment fund. The fund positions Canaan to place a fresh round of bets on early-stage biotechs, continuing…
Read More
USM Names David W. Wise Director of Maryland Momentum Fund – University of Maryland, Baltimore
The University System of Maryland (USM) has named business innovator David W. Wise, MALD, as director of the Maryland Momentum Fund (MMF), a $25…
Read More
University venturing: 2017 first half review – Global University Venturing
Global University Venturing’s last issue before the summer provides an opportunity to look back at the first six months of the year – as…
Read More
UMB Named ‘Great College to Work For’ – University of Maryland, Baltimore
The University of Maryland, Baltimore (UMB) has been selected as one of "The Great Colleges to Work For" by The Chronicle of Higher Education.…
Read MoreCanada boasts buoyant biotech sector – Innovators magazine
The global population will increase to almost ten billion by 2050 while greenhouse gas emissions from agriculture continue to rise. We need to intensify…
Read More
Aussie biotech startup Trimph produces world-first bone “glue”
Australian biotech, Trimph, has successfully completed a first-in-human trial of its proprietary bone “glue”, TrimphDent, the only bone graft substitute in the world to be applied in…
Read More